Impetigo Treatment
For localized impetigo (fewer than 10 lesions), treat with topical mupirocin or retapamulin twice daily for 5 days; for extensive disease or multiple affected individuals, use oral antibiotics for 7 days—specifically dicloxacillin or cephalexin for methicillin-susceptible S. aureus, or clindamycin, doxycycline, or trimethoprim-sulfamethoxazole when MRSA is suspected. 1
Treatment Algorithm by Disease Extent
Localized Disease (< 10 lesions, < 36 cm² area)
First-line topical therapy:
Alternative topical option:
Extensive Disease or Outbreak Settings
Oral antibiotics are mandatory when:
- Numerous lesions are present
- Multiple people are affected (to decrease transmission)
- Ecthyma is present (always requires oral therapy) 1
Oral antibiotic selection (7-day course):
For methicillin-susceptible S. aureus (most common):
When MRSA is suspected or confirmed:
If cultures yield streptococci alone:
- Oral penicillin is the recommended agent 1
Important caveat: Penicillin alone is inferior to other options when S. aureus is involved—studies show erythromycin (RR 1.29) and cloxacillin (RR 1.59) significantly outperform penicillin 2
Key Clinical Considerations
Culture Recommendations
While Gram stain and culture of lesion exudates help identify whether S. aureus and/or β-hemolytic Streptococcus is the causative organism, treatment without these studies is reasonable in typical cases 1. The decision to culture should be based on:
- Severity of infection
- Treatment failure
- Outbreak situations
- Local MRSA prevalence
Topical vs. Oral Therapy Comparison
The evidence shows topical mupirocin is slightly superior to oral erythromycin (RR 1.07) 2. However, oral therapy becomes necessary for extensive disease where topical application is impractical. The 2024 WHO guidelines confirm that amoxicillin-clavulanate, dicloxacillin, cefuroxime, and cephalexin all provide appropriate Gram-positive coverage for mild-to-moderate skin infections 4.
Antimicrobial Resistance Concerns
Critical pitfall: Growing resistance to commonly used antibiotics worldwide necessitates knowledge of local resistance patterns 5, 6. Mupirocin, retapamulin, and fusidic acid resistance has been widely reported 5. This makes newer agents like ozenoxacin particularly valuable, as no resistance has yet been reported 2, 3.
Special Circumstances
During outbreaks of poststreptococcal glomerulonephritis:
- Systemic antimicrobials should be used to eliminate nephritogenic strains of S. pyogenes from the community 1
In endemic settings (e.g., resource-limited areas):
- Oral co-trimoxazole and benzathine benzylpenicillin G injection show equal effectiveness for severe impetigo 3
- Mass drug administration strategies may be considered as a public health intervention 3
Common Pitfalls to Avoid
Do not use penicillin alone when S. aureus is suspected—it shows inferior cure rates compared to anti-staphylococcal agents 2
Avoid relying on disinfectants as primary therapy—topical antibiotics are significantly superior to disinfecting treatments (RR 1.15) 2
Do not underestimate extent of disease—if lesions are numerous or spreading rapidly, oral therapy is required from the outset rather than attempting topical treatment first 1
Consider MRSA prevalence in your region—if MRSA rates are high, empiric coverage with clindamycin, doxycycline, or TMP-SMX is warranted rather than beta-lactams 1
The strength of these recommendations comes from the 2014 IDSA guidelines 1, which remain the gold standard, supplemented by the 2024 WHO essential medicines recommendations 4 that reinforce appropriate antibiotic selection for skin and soft tissue infections.